Pauff JM - Search Results

1

Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma.

Kaufman JL, Gasparetto C, Schjesvold FH, Moreau P, Touzeau C, Facon T, Boise LH, Jiang Y, Yang X, Dunbar F, Vishwamitra D, Unger S, Macartney T, Pesko J, Yu Y, Salem AH, Ross JA, Hong WJ, Maciag PC, Pauff JM, Kumar S. Kaufman JL, et al. Among authors: pauff jm. Am J Hematol. 2021 Apr 1;96(4):418-427. doi: 10.1002/ajh.26083. Epub 2021 Jan 19. Am J Hematol. 2021. PMID: 33368455 Free PMC article. Clinical Trial.

2

Systematic review of infectious events with the Bruton tyrosine kinase inhibitor ibrutinib in the treatment of hematologic malignancies.

Tillman BF, Pauff JM, Satyanarayana G, Talbott M, Warner JL. Tillman BF, et al. Among authors: pauff jm. Eur J Haematol. 2018 Apr;100(4):325-334. doi: 10.1111/ejh.13020. Epub 2018 Feb 6. Eur J Haematol. 2018. PMID: 29285806 Review.

3

Current Progress in Immunotherapy for the Treatment of Biliary Cancers.

Pauff JM, Goff LW. Pauff JM, et al. J Gastrointest Cancer. 2016 Dec;47(4):351-357. doi: 10.1007/s12029-016-9867-8. J Gastrointest Cancer. 2016. PMID: 27538880 Review.

4

Post-allograft pomalidomide and reversible hepatotoxicity.

Pauff JM, Gonzalez RS, Sajnani KP, Kassim A, Jagasia M. Pauff JM, et al. Bone Marrow Transplant. 2014 Oct;49(10):1341-2. doi: 10.1038/bmt.2014.128. Epub 2014 Jun 23. Bone Marrow Transplant. 2014. PMID: 24955783 No abstract available.

5

Treatment of metastatic pancreatic adenocarcinoma: a review.

Thota R, Pauff JM, Berlin JD. Thota R, et al. Among authors: pauff jm. Oncology (Williston Park). 2014 Jan;28(1):70-4. Oncology (Williston Park). 2014. PMID: 24683721 Free article. Review.

6

X-ray crystal structure of a xanthine oxidase complex with the flavonoid inhibitor quercetin.

Cao H, Pauff JM, Hille R. Cao H, et al. Among authors: pauff jm. J Nat Prod. 2014 Jul 25;77(7):1693-9. doi: 10.1021/np500320g. Epub 2014 Jul 1. J Nat Prod. 2014. PMID: 25060641

7

Substrate orientation and catalytic specificity in the action of xanthine oxidase: the sequential hydroxylation of hypoxanthine to uric acid.

Cao H, Pauff JM, Hille R. Cao H, et al. Among authors: pauff jm. J Biol Chem. 2010 Sep 3;285(36):28044-53. doi: 10.1074/jbc.M110.128561. Epub 2010 Jul 8. J Biol Chem. 2010. PMID: 20615869 Free PMC article.

8

Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.

Pauff JM, Hille R. Pauff JM, et al. J Nat Prod. 2009 Apr;72(4):725-31. doi: 10.1021/np8007123. J Nat Prod. 2009. PMID: 19388706 Free PMC article.

9

Substrate Orientation and Catalysis at the Molybdenum Site in Xanthine Oxidase: CRYSTAL STRUCTURES IN COMPLEX WITH XANTHINE AND LUMAZINE.

Pauff JM, Cao H, Hille R. Pauff JM, et al. J Biol Chem. 2009 Mar 27;284(13):8760-7. doi: 10.1074/jbc.M804517200. Epub 2008 Dec 24. J Biol Chem. 2009. PMID: 19109252 Free PMC article.

10

Substrate orientation in xanthine oxidase: crystal structure of enzyme in reaction with 2-hydroxy-6-methylpurine.

Pauff JM, Zhang J, Bell CE, Hille R. Pauff JM, et al. J Biol Chem. 2008 Feb 22;283(8):4818-24. doi: 10.1074/jbc.M707918200. Epub 2007 Dec 6. J Biol Chem. 2008. PMID: 18063585 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page